Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (371-380 of 392) with videos related to

Pageof 40
Sort By:
Cancer Cell|September 20, 2024
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulationYang Gao, Jianan Li, Wenfeng Cheng, et al.
Cellular & Molecular Immunology|August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumorsZhenguang Wang, Na Li, Kaichao Feng, et al.
Scientific Reports|February 10, 2021
Retraction Note: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagyXinbing Sui, Na Kong, Xian Wang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALLChanglin Yu, Bo Cai, Yao Wang, et al.
Frontiers in Immunology|October 17, 2022
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapyJiawei Shou, Fan Mo, Shanshan Zhang, et al.
BMC Cancer|April 10, 2024
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumorsYe Guo, Zishu Wang, Huan Zhou, et al.
International Journal of Cancer|November 7, 2019
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironmentWeiting Ge, Hanguang Hu, Wen Cai, et al.
Plos One|May 23, 2014
Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activationXinbing Sui, Yinghua Xu, Jie Yang, et al.
Chinese Medical Journal|April 3, 2024
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphomaSanfang Tu, Ping Li, Heng Mei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2022
Identification of a STIM1 Splicing Variant that Promotes Glioblastoma GrowthJiansheng Xie, Guolin Ma, Lijuan Zhou, et al.
Pageof 40

Showing results (371-380 of 392) with videos related to

Sort By:
Pageof 40
Cancer Cell|September 20, 2024
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulationYang Gao, Jianan Li, Wenfeng Cheng, et al.
Cellular & Molecular Immunology|August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumorsZhenguang Wang, Na Li, Kaichao Feng, et al.
Scientific Reports|February 10, 2021
Retraction Note: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagyXinbing Sui, Na Kong, Xian Wang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALLChanglin Yu, Bo Cai, Yao Wang, et al.
Frontiers in Immunology|October 17, 2022
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapyJiawei Shou, Fan Mo, Shanshan Zhang, et al.
BMC Cancer|April 10, 2024
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumorsYe Guo, Zishu Wang, Huan Zhou, et al.
International Journal of Cancer|November 7, 2019
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironmentWeiting Ge, Hanguang Hu, Wen Cai, et al.
Plos One|May 23, 2014
Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activationXinbing Sui, Yinghua Xu, Jie Yang, et al.
Chinese Medical Journal|April 3, 2024
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphomaSanfang Tu, Ping Li, Heng Mei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2022
Identification of a STIM1 Splicing Variant that Promotes Glioblastoma GrowthJiansheng Xie, Guolin Ma, Lijuan Zhou, et al.
Pageof 40